Aortic Valve Disease

Research

Mayo Clinic physicians and surgeons are leaders in research related to the diagnosis and treatment of aortic valve disease.

Recent research publications

A report from the American Society of Echocardiography's Nomenclature Standards Committee, The Task Force on Valvular Regurgitation, developed in conjunction with the American College of Cardiology Echocardiography Committee, The Cardiac Imaging Committee Council on Clinical Cardiology, the American Heart Association, the European Society of Cardiology Working Group on Echocardiography, represented by: Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Q Recommendations for Evaluation of the Severity of Native Valvular Regurgitation with Two-dimensional and Doppler Echocardiography. J Am Soc Echocardiogr 2003; 16:777-802. [No Abstract Available]

Nkomo VT, Enriquez-Sarano M, Ammash NM, Melton LJ, Bailey KR, Desjardins V, Horn RA, Tajik AJ. Bicuspid aortic valve associated with aortic dilatation – A community-based study. Arteriosclerosis Thrombosis & Vascular Biology 2003 Feb; 23(2):351-6. [Abstract]

Quere JP, Tribouilloy C, Enriquez-Sarano M. Vena contracta width measurement: Theoretic basis and usefulness in the assessment of valvular regurgitation severity. Curr Cardiol Rep 2003; 5(2):110-5. [Abstract]

Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ. Guidelines: American Society of Echocardiography: Recommendations for Evaluation of the Severity of Native Valvular Regurgitation with Two-Dimensional and Doppler Echocardiography. A Report from the American Society of Echocardiography's Nomenclature and Standards Committee and The Task Force on Valvular Regurgitation, Developed in Conjunction with the American College of Cardiology Echocardiography Committee, The Cardiac Imaging Committee, Council on Clinical Cardiology, The American Heart Association, Euro J Echocardiography December 2003; 4:237-261. [No Abstract Available]

Chaliki HP, Mohty D, Avierinos JF, Scott CG, Schaff HV, Tajik AJ, Enriquez-Sarano M. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation 2002 Nov 19; 106(21):2687-93. [Abstract]

Enriquez-Sarano M. Recent clinical trials in valvular heart diseases. Curr Cardiol Rep 2002 Mar; 4(2):85-7. [No Abstract Available]

Nkomo VT, Enriquez-Sarano M. Chronic Severe Aortic Regurgitation. Cardiac Ultrasound Today 2002; 8(2/3):21-52. No Abstract Available]

Tribouilloy CM, Enriquez-Sarano M, Capps MA, Bailey KR, Tajik AJ. Contrasting effect of similar effective regurgitant orifice area in mitral and tricuspid regurgitation: A quantitative Doppler echocardiographic study. J Am Soc Echocardiogr 2002 Sep; 15(9):958-65. [Abstract]

Tsang TSM, Enriquez-Sarano M, Freeman WK, Barnes ME, Sinak LJ, Gersh BJ, Bailey KR, Seward JB. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: Clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc 2002 May; 77(5):429-36. [Abstract]

Messika-Zeitoun M, Aubry MC, Detaint D, Beilak LF, Peyser PA, Sheedy PF, Turner ST, Breen JF, Scott C, Tajik AJ, Enriquez-Sarano M. Evaluation and Clinical Implications of Aortic Valve Calcification Measured by Electron-Beam Computed Tomography. Circulation 2004; 110:356-362. [Abstract]

Peltier M, Trojette F, Sarano ME, Grigioni F, Slama MA, Tribouilloy CM. Relation between cardiovascular risk factors and nonrheumatic severe calcific aortic stenosis among patients with a three-cuspid aortic valve. Am J Cardiol 2003 Jan 1; 91(1):97-9. [No Abstract Available]

Malouf JF, Enriquez-Sarano M, Pellikka PA, Oh JK, Bailey KR, Chandrasekaran K, Mullany CJ, Tajik J. Severe pulmonary hypertension in patients with severe aortic valve stenosis: Clinical profile and prognostic implications. J Am Coll Cardiol 2002 Aug 21; 40(4):789-95. [Abstract]